Nice announcement with US and European registration of the own branded cryovials, and the market seems to have liked it too with shares up over 20%. Now to see how this plays out and if they can continue to execute.

For those that are not aware, the company plays in the cryogenic space. The business produces identification tags to ensure tracking and provides confidence. This tech is backed by multiple global patents. The product has been sold to OEM in IVF, and cryogenic consumables (biobanking).

This is a narrow, but important industry with an ever-increasing focus on health, and with a world becoming more and more litigious.

The company is not sitting on their hand and is looking at other aligned cold storage and cold logistics applications in health care.

They seem to have gotten out/ over the Labcon litigation which also removes a real risk.

Currently sitting on 6M cash but burning around 1M per quarter.

Not held, but on the watchlist.